S.P. Akshara*, M. Arumugavignesh, M. Abdulla, P. Jeevitha Lakshmi, P. Jessica


Pyoderma gangrenosum is a reactive non-infectious inflammatory dermatoses falling under the spectrum of the neutrophilic dermatoses. Pyoderma gangrenosum is not caused by infection or gangrene. There is a female predominance in this disease. Presenting a clinical case of a young female patient with Pyoderma gangrenosum and discussing about her disease‟s pathophysiology along with treatment provided for her is the specific objective of this case study. A 27 years old female patient with complaints of fluid filled pustules, dark colored and itchy patches over the legs for the past four months was admitted to the general medicine department of the hospital. On investigation, blood report showed that the patient was anaemic. The local examination of patient revealed the presence of multiple hyper pigmentation and dark coloured plaques with oozing over both legs. The patient had been given cefotaxime 1g intravenously every twelve hourly. Ranitidine 50mg was administered before food every twelve hourly via intravenous route. The given antibiotics for this patient were indicated towards the treatment of eczema, which is feared to be a complication of pyoderna. The lesions were only partially healed by treating with antibiotics. For complete remission, immunosuppressants and corticosteroids therapy is absolutely necessary for this patient. Anaemia is often under diagnosed in these busy hospital settings. It must be properly monitored in order to avoid complications associated with anaemia in women of child-bearing age.

Keywords: Pyoderma gangrenosum, corticosteroids, immunosuppressants, anaemia.

[Full Text Article]


Forgot Password  |  Register


Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation


    DECEMBER 2023 Issue has been successfully launched on 1 DECEMBER 2023.

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.


UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS


Copyright From

Covering Letter

                        Author Instruction